By
Jaclyn Jaeger2021-09-07T19:08:00
The U.S. Food and Drug Administration’s “intended use” final rule reaffirms the agency’s wide latitude of discretion in establishing an off-label use case against pharmaceutical and medical device companies.
2025-01-15T19:05:00Z By Oscar Gonzalez
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
2025-11-03T19:09:00Z By Ruth Prickett
The energy sector faces rising regulatory activity, with more rules and enforcement. Bribery, corruption, and sanctions now dominate compliance concerns, driving rapid change and pressure on compliance officers.
2025-11-03T17:28:00Z By Kayla Underkoffler, CW guest columnist
The current AI policy and regulation landscape is still emerging globally. While some regulations and standards exist, governments, industry, and security leaders have critical gaps to close, especially around agentic artificial intelligence.
2025-10-31T17:50:00Z By Adrianne Appel
The U.S. government shutdown has brought most operations at the Securities and Exchange Commission (SEC) to a screeching halt, but that doesn’t mean compliance teams should be taking a breather, experts advised.
2025-10-30T19:39:00Z By Neil Hodge
Companies could face significant compliance challenges in trying to meet new EU legal requirements about how companies share data with third parties.
2025-10-27T20:16:00Z By Adrianne Appel
California has delayed the release of draft greenhouse gas reporting rules for businesses until early 2026, the California Air Resources Board said.
Site powered by Webvision Cloud